Biotecnología
Biotecnología
Sartorius, SPARTA Biodiscovery Partner on Nanoparticle Analysis Platform
29/09/2023 -
SPARTA technology aims to accelerate development, manufacture and QC of nanoparticles used for gene therapies, vaccines, and cancer drugs.
WuXi Vaccines Launches Vaccines CDMO Site in China
27/09/2023 -
Aims to add drug substance and drug product capacity, with services for diversified vaccines.
GenScript Adds Circular RNA, Lipid Nanoparticles Formulation
19/09/2023 -
Aims to offer comprehensive range of RNA formats critical, enabling fast delivery of complex design for the R&D of RNA vaccines and therapeutics.
Fujifilm Diosynth Opens Viral Vector Gene Therapy Facility in UK
18/09/2023 -
Facility is cGMP operational for manufacturing of viral gene therapies, oncolytic viruses, and viral vaccines for clinical trials.
Samsung Biologics Enters Research Collaboration with AimedBio
14/09/2023 -
Aims to foster next-gen biotechnologies.
Rentschler Biopharma’s ATMP UK Facility Receives MHRA Approval
14/09/2023 -
Facility offers services from early process and analytical development through cGMP manufacturing for clinical trials.
BARDA, ICON Partner to Execute Next-Gen COVID Vaccine Trial
14/09/2023 -
ICON will execute a Phase 2b clinical trial to assess the relative efficacy of a next generation COVID-19 vaccine.
Eminence Opens GMP Cell Culture Media Manufacturing Facility
13/09/2023 -
Aims to address the rapidly growing demand for high-quality media in the fields of vaccines, gene, cell therapies, antibodies, and recombinant proteins.
KBI Biopharma Launches SUREmAb Monoclonal Antibody Offering
13/09/2023 -
Designed to streamline processes and provide greater efficiencies in monoclonal antibody development and manufacturing.
Solu Therapeutics Names Philip Vickers President and CEO
13/09/2023 -
Vickers brings more than 30 years of experience in the biopharma industry.
Moderna, Immatics Partner on R&D for Cancer Immunotherapies
13/09/2023 -
To leverage Immatics' TCR platform with Moderna's mRNA technology across therapeutic modalities including bispecifics, cell therapy and cancer vaccines.
Danforth Advisors Acquires Elite BioPharma Consulting
07/09/2023 -
Acquisition adds clinical development operations to range of capabilities.
Hansa Biopharma Names Hitto Kaufmann Chief Scientific Officer
04/09/2023 -
Kaufmann will be responsible for research, early development, translational and manufacturing activities.
Advent International, Warburg Pincus Name Franco Negron CEO of BioPharma Solutions
01/09/2023 -
Negron has 30 years of experience in the pharmaceutical industry including president of commercial operations at Thermo Fisher Scientific.
MHRA Approves Roche's Tecentriq Subcutaneous with ENHANZE
01/09/2023 -
Co-formulated with Halozyme's recombinant human hyaluronidase enzyme, rHuPH20, allowing for subcutaneous delivery.
Pfizer’s ABRYSVO for Infant RSV Prevention Approved in Pregnant Women
28/08/2023 -
First and only U.S. approval of a maternal vaccine to help protect infants at birth through six months of life from lower respiratory tract disease.
Fujifilm Diosynth Biotechnologies Unveils Strategic Customer-Focused Business Structure
28/08/2023 -
New unit to provide tailored support to large-and small-scale biopharmaceutical customers.
Willow Partners with Biopharma Firm to Develop Pharmaceutical Ingredients
22/08/2023 -
Aims to employ new sustainable routes to key intermediates and APIs.
Sartorius, Repligen Partner on Integrated Bioreactor System
18/08/2023 -
Bioreactor and cell technology features a single direct control interface to simplify intensified seed train implementation.
Chiesi, Aliada Therapeutics Enter Drug Delivery Alliance
17/08/2023 -
Will focus on enzyme cargoes modified with Aliada's MODEL delivery platform to move large molecule therapeutics across the blood-brain barrier.
Wheeler Bio Names Marc Helouin Chief Quality and Regulatory Officer
16/08/2023 -
Helouin brings 25 years of experience in biopharma across multiple domains including supply chain assurance, clinical and commercial compliance.
